• Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
  

PubMed=28700270; DOI=10.1089/mab.2017.0026; PMCID=PMC6985780
Shunsuke Itai, Yuki Fujii, Mika Kato Kaneko, Shinji Yamada, Takuro Nakamura, Miyuki Yanaka, Noriko Saidoh, Yao-Wen Chang, Saori Handa, Maki Takahashi, Hiroyoshi Suzuki ...Show all 13 authors... , Hiroyuki Harada, Yukinari Kato; Show fewer authors
H2Mab-77 is a sensitive and specific anti-HER2 monoclonal antibody against breast cancer.
Monoclon. Antib. Immunodiagn. Immunother. 36:143-148(2017)

PubMed=29172998; DOI=10.1089/mab.2017.0050
Shinji Yamada, Shunsuke Itai, Takuro Nakamura, Yao-Wen Chang, Hiroyuki Harada, Hiroyoshi Suzuki, Mika Kato Kaneko, Yukinari Kato;
Establishment of H2Mab-119, an anti-human epidermal growth factor receptor 2 monoclonal antibody, against pancreatic cancer.
Monoclon. Antib. Immunodiagn. Immunother. 36:287-290(2017)

PubMed=29315012; DOI=10.1089/mab.2017.0052
Mika Kato Kaneko, Shinji Yamada, Shunsuke Itai, Yukinari Kato;
Development of an anti-HER2 monoclonal antibody H2Mab-139 against colon cancer.
Monoclon. Antib. Immunodiagn. Immunother. 37:59-62(2018)

PubMed=31199696; DOI=10.1089/mab.2019.0017
Yukinari Kato, Tomokazu Ohishi, Shinji Yamada, Shunsuke Itai, Junko Takei, Masato Sano, Takuro Nakamura, Hiroyuki Harada, Manabu Kawada, Mika Kato Kaneko;
Anti-human epidermal growth factor receptor 2 monoclonal antibody H2Mab-41 exerts antitumor activity in a mouse xenograft model of colon cancer.
Monoclon. Antib. Immunodiagn. Immunother. 38:157-161(2019)

PubMed=32765652; DOI=10.3892/etm.2020.8765; PMCID=PMC7388441
Junko Takei, Mika Kato Kaneko, Tomokazu Ohishi, Manabu Kawada, Hiroyuki Harada, Yukinari Kato;
H2Mab-19, an anti-human epidermal growth factor receptor 2 monoclonal antibody exerts antitumor activity in mouse oral cancer xenografts.
Exp. Ther. Med. 20:846-853(2020)

PubMed=34424764; DOI=10.1089/mab.2021.0021
Junko Takei, Teizo Asano, Tomohiro Tanaka, Masato Sano, Hideki Hosono, Ren Nanamiya, Nami Tateyama, Masaki Saito, Hiroyoshi Suzuki, Hiroyuki Harada, Mika Kato Kaneko, Yukinari Kato;
Development of a novel anti-HER2 monoclonal antibody H2Mab-181 for gastric cancer.
Monoclon. Antib. Immunodiagn. Immunother. 40:168-176(2021)